We comprehensively probed into the roles of Solute carrier family 7 member 11 (SLC7A11), a ferroptosis regulatory gene in prognosis, immune microenvironment, biological metabolism, therapeutic correlation, and pro‐oncogenic abilities of renal cell carcinoma (RCC) through bioinformatic analyses and experimental validation. The gene discussed is SLC17A1; the disease is renal cell carcinoma.